Nova Eye Medical Limited Sustainability Profile
Nova Eye Medical Limited, headquartered in Australia, is a pioneering company in the ophthalmic medical device industry. Founded in 2017, it has quickly established itself as a leader in innovative solutions for eye care, particularly in the fields of glaucoma and cataract treatment. The company’s flagship products, including the iTrack™ and the KDB™ (Kahook Dual Blade), are renowned for their unique design and effectiveness, setting new standards in minimally invasive surgical techniques. With a strong presence in major operational regions such as North America and Europe, Nova Eye Medical has achieved significant milestones, including regulatory approvals and successful clinical outcomes that underscore its commitment to advancing eye health. Recognised for its cutting-edge technology and dedication to improving patient outcomes, Nova Eye Medical continues to solidify its market position as a trusted name in ophthalmology.
DitchCarbon Score
How does Nova Eye Medical Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Nova Eye Medical Limited's score of 14 is lower than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Nova Eye Medical Limited's reported carbon emissions
Nova Eye Medical Limited, headquartered in Australia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Nova Eye Medical may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the medical technology sector, companies are increasingly expected to adopt transparent climate strategies and set measurable targets for emissions reduction. However, without specific emissions data or commitments, it is challenging to assess Nova Eye Medical's environmental impact or its alignment with industry best practices.
How Carbon Intensive is Nova Eye Medical Limited's Industry?
How Carbon Intensive is Nova Eye Medical Limited's Location?
Nova Eye Medical Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Nova Eye Medical Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
